Table 5.
Events after treatment.
Event | SBRT (n = 95) | CCRT (n = 66) | p Value |
---|---|---|---|
Curative resection | 7 (7.4%) | 2 (3.0%) | 0.311 |
* Treatment-related toxicity (≥Grade 3) | |||
Acute | 3 (3.2%) | 5 (7.6%) | 0.274 |
Late | 2 (2.1%) | 1 (1.5%) | 1.000 |
First site of treatment failure | 79 (83.2%) | 56 (84.8%) | 0.102 |
Local | 12 (12.6%) | 17 (25.8%) | - |
Distant | 55 (57.9%) | 31 (47.0%) | - |
Both | 12 (12.6%) | 8 (12.1%) | - |
Abbreviations: SBRT, stereotactic body radiotherapy; CCRT, concurrent chemoradiotherapy. * Toxicity was assessed using Common Terminology Criteria for Adverse Events, version 4.0 (https://ctep.cancer.gov/protocoldevelopment/electronic_applications/ctc.htm, accessed on 23 February 2022). Events reported within 90 days after RT were classified as acute toxicities, whereas those occurring after 90 days were considered as late toxicities.